Thursday, 29 September 2022

 

 

LATEST NEWS Jai Ram Thakur inaugurates and lays foundation stone of 14 developmental projects worth Rs. 29 crore at Janjehli DEAKIN UNIVERSITY HUB to be set up at Chitkara University with key objective to progress the internationalisation of education World Heart Day celebrated at CGC Landran “We You will see Deepika and me together soon : Ranveer Singh Jai Ram Thakur Visits AIIMS at Kothipura State Election Commissioner Presents Report on By-election Jai Ram Thakur reviews arrangements for PM visit at Bilaspur HCMCT Manipal Hospitals, collaborates with Delhi Traffic Police and Cult.Fit to raise awareness on heart health on World Heart Day The ‘Heart Truth’ - Why heart attacks are on the rise among women New Zealand, United Arab Emirates reveal official jerseys for 2022 Men's T20 World Cup Wanted shooter of Bambiha gang arrested by Punjab Police Looking into matter of woman IAS officer's sharp words for school girl : Nitish Kumar Gajraj Rao was initially scared to sign on the dotted line for 'Maja Ma' Parineeti Chopra learnt Krav Maga for three months for 'Code Name Tiranga' People from the outside might be surprised but team knew about his skill : Mitchell Marsh on Cameron Green Jasprit Bumrah to be ruled out of T20 World Cup with back stress fracture : Report Arjun Kanungo, Tulsi Kumar's 'Killer Haseena' is lethal, gothic and mysterious Leopard Died While Collision With Speedy Car In Seoni Nagpur Highway Neeraj Chaska Sharp Shooter From Bambiha Gangster Got Arrested IANS Review : 'Vikram Vedha': Hrithik Roshan, Saif Ali Khan shine in this mass entertainer After 0-7 drubbing by Australia in CWG, India training to avoid early goals in hockey World Cup : Nilakanta Sharma

 

New Covid-like rapid test to spot cancers, heart disease more easily

Health, Study, London, Research, Researchers, World News

Web Admin

Web Admin

5 Dariya News

London , 07 Aug 2022

A team of international researchers from the UK, US and Germany, has built a new easy-to-use test that could diagnose non-infectious diseases like heart attacks and cancers more quickly.

The new test, called CrisprZyme, works by detecting molecular signals in the body called biomarkers, which are already used in things like Covid-19 testing where the presence of SARS-CoV-2 genes indicates Covid.

There are also biomarkers for non-infectious diseases: for example, prostate specific antigen (PSA) in the blood can sometimes act as a biomarker to indicate the presence of prostate cancer.

Diagnostic tests based on RNA or DNA often require controlled temperatures and involve multiple steps. The new test can be used at room temperature in a user-friendly process.

The researchers hope this could enable quicker and easier diagnostics in settings like GP surgeries, as well as in resource-limited clinics in developing countries.

"As well as potentially boosting access to diagnostics in developing countries, this technology could bring us a step closer to personalised diagnostics at home or at the GP surgery," said Dr Marta Broto, Department of Materials, Imperial University.

"By making clinical diagnostic tests simpler, we will be able to provide clinicians with the right tools to test at the same GP surgery instead of having to reschedule for follow-up analyses and blood tests," she added.

CrisprZyme builds on CRISPR diagnostic tests, which use RNA, the messenger that helps create proteins, to detect biomarkers in biological fluids like blood or urine.

CrisprZyme improves the technology by replacing the amplification process with colorimetric analysis - a method that determines the amount of biomarker present without the need for amplification.

This eliminates the need for temperature control and additional steps, and can also reveal how much of a biomarker is present in a sample, the team explained in the paper published in the journal Nature Nanotechnology.

"Following further development and testing in the lab, we hope this could help take us a step closer to personalised medicine whereby treatment is tailored more specifically to patients' needs," said Professor Molly Stevens FRS FREng, of Imperial's Departments of Materials and Bioengineering.

 

Tags: Health , Study , London , Research , Researchers , World News

 

 

related news

 

 

 

Photo Gallery

 

 

Video Gallery

 

 

5 Dariya News RNI Code: PUNMUL/2011/49000
© 2011-2022 | 5 Dariya News | All Rights Reserved
Powered by: CDS PVT LTD